Purchase Order 75N98026P00201
- Not listed
- The National Cancer Institute awarded a $18,944 firm fixed price BPA call to Lonza Walkersville, Inc. for a 4D-Nucleofector X Unit. The contract was awarded on September 20, 2022, with an ultimate completion date of September 19, 2023, and will be performed at the awardee's location in Bethesda, Maryland. This procurement was conducted through open competition with no set-aside designation. Lonza Walkersville is a Maryland-based subsidiary of the global Lonza Group specializing in biological...
- The NIH Clinical Center awarded a $23,613.01 firm fixed-price purchase order to Lonza Walkersville, Inc. for procurement of a 4D-Nucleofector System. The contract, awarded on September 3, 2025, with completion targeted for September 2, 2026, represents an open competition award with no set-aside designation. Lonza Walkersville, a foreign-owned biological materials and laboratory equipment manufacturer based in Walkersville, Maryland, will perform the work at its local facility. The...
- The National Cancer Institute awarded a $19,129.24 firm fixed-price contract to Lonza Walkersville, Inc. for laboratory equipment through a Blanket Purchase Agreement (BPA) call. The contract was awarded on July 8, 2021, with an ultimate completion date of August 7, 2021. Lonza Walkersville, a foreign-owned manufacturer of biological materials and laboratory equipment located in Walkersville, Maryland, was selected through open competition with no set-aside designation applied to this...
- The National Cancer Institute awarded a $18,000 firm fixed price BPA call to Lonza Walkersville, Inc. on June 24, 2021, with an ultimate completion date of August 31, 2021. This contract was executed without set-aside designation, indicating open competition. The award supports the provision of transfection technology and related scientific equipment to be delivered at Lonza's Walkersville, Maryland facility. Transfection is a critical laboratory technique used to introduce genetic material into...
- This is a firm-fixed-price contract awarded by the National Cancer Institute, a component of the Department of Health and Human Services, to Lonza Walkersville, Inc. The $24,220.01 contract is for the delivery of 4D Nucleofector Core UNI equipment and related products. Lonza Walkersville is a for-profit manufacturer and supplier of specialized biological materials, laboratory equipment, and scientific services. This award is not set-aside and is a call against an existing Blanket Purchase...
- The National Center for Complementary and Integrative Health (NCCIH) awarded a $2,625 purchase order to Lonza Walkersville, Inc. on August 13, 2009, for the procurement of a Nucleofector device (Serial #10700806) and a 96-well Shuttle system (Serial #307S0245) with quarterly payments in arrears. The contract was completed by February 22, 2010, with performance occurring at Lonza's Walkersville, Maryland facility. No set-aside designation was utilized for this procurement, indicating open...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $13,818 purchase order to Lonza Walkersville, Inc. Walkersville Division for scientific supplies. The firm fixed price contract has a period of performance from July 25, 2023 through September 24, 2023 for supplies to be delivered to the prime contractor's facility in Walkersville, Maryland. No additional details were provided regarding the scope of supplies requested under the...
- The Department of Health and Human Services' National Institutes of Health's National Cancer Institute awarded a Blanket Purchase Agreement call contract valued at twenty-four thousand two hundred twenty dollars and one cent ($24,220.01) to Lonza Walkersville, Inc. for equipment. The contract has a firm fixed price and period of performance through March 22, 2024. Lonza Walkersville, Inc. will deliver the equipment from its Walkersville, Maryland location in support of the National Cancer...
- Lonza Walkersville, Inc. was awarded a firm fixed-price BPA call valued at $24,179.40 for a PART AAF-1002B 4D Nucleofector Core Unit, FL1 by the National Institutes of Health Office of the Director. The award, issued on July 23, 2015, with an ultimate completion date of December 31, 2015, was made without a set-aside designation, indicating open competition. The equipment will be delivered to the NIH campus in Bethesda, Maryland. This procurement leverages Lonza Walkersville's existing $10...
- This firm fixed-price purchase order was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Lonza Walkersville, Inc., a foreign-owned for-profit manufacturer of laboratory equipment and scientific supplies. The $22,703.01 contract is for the provision of a Lonza 4D Nucleofector transfection instrument and associated component parts to support genome engineering research using CRISPR-Cas9 technology, particularly...
The National Cancer Institute awarded a $19,287.85 firm fixed-price purchase order to Lonza Walkersville, Inc. for a 4D-Nucleofector Core Unit and X Unit. The contract, awarded on March 31, 2026, with an ultimate completion date of March 30, 2027, represents a direct procurement with no set-aside designation, indicating open competition. Lonza Walkersville, a foreign-owned, for-profit manufacturer specializing in biological materials and advanced scientific instrumentation, will perform the work at its facility in Walkersville, Maryland. The Nucleofector systems being procured are sophisticated transfection devices widely used in cellular research and regenerative medicine applications, supporting the NCI's mission to conduct and fund cancer research across the nation. This award reflects the established procurement relationship between the National Cancer Institute and Lonza Walkersville, Inc., a critical supplier of specialized research equipment to federal biomedical research institutions. The vendor holds a $10 million Blanket Purchase Agreement with the HHS Office of Logistics and Acquisition Operations that facilitates streamlined procurement of biological materials, laboratory supplies, and scientific equipment across multiple NIH institutes. Through its consistent delivery of high-precision research products and equipment, Lonza Walkersville has demonstrated its capability to support the complex instrumentation needs of federal cancer research initiatives and other life sciences applications throughout the federal research enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.3k | 3/29/26 |